David A. Sallman
- Hematology top 0.2%
- Molecular Biology top 5%
- Genetics top 0.5%
- Oncology top 2%
- Immunology top 5%
- Co-authors
- Alan F. ListRami S. KomrokjiEric PadronJeffrey E. LancetKendra SweetThomas CluzeauKathy L. McGrawAnthony M. Hunter
- Topics
- Acute Myeloid Leukemia Research (218 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (82 papers)Chronic Myeloid Leukemia Treatments (49 papers)
- Cited by
- HematologyGeneticsImmunology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
David A. Sallman
262 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 87
- Hematology 2.6k
- Molecular Biology 1.6k
- Genetics 1.0k
- Oncology 992
- Immunology 869
Countries citing papers authored by David A. Sallman
This map shows the geographic impact of David A. Sallman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Sallman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Sallman more than expected).
Fields of papers citing papers by David A. Sallman
This network shows the impact of papers produced by David A. Sallman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Sallman. The network helps show where David A. Sallman may publish in the future.
Co-authorship network of co-authors of David A. Sallman
This figure shows the co-authorship network connecting the top 25 collaborators of David A. Sallman. A scholar is included among the top collaborators of David A. Sallman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Sallman. David A. Sallman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 7 | |
| 10 | 7 | |
| 11 | 9 | |
| 12 | 83 | |
| 13 | 7 | |
| 14 | 21 | |
| 15 | 2 | |
| 16 | 13 | |
| 17 | 14 | |
| 18 | The First-in-Class Anti-CD47 Antibody Magrolimab Combined with Azacitidine Is Well-Tolerated and Effective in AML Patients: Phase 1b Results | 26 |
| 19 | 22 | |
| 20 | 35 |
About David A. Sallman
David A. Sallman is a scholar working on Hematology, Genetics and Immunology, having authored 293 papers that have together received 3.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (218 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (82 papers) and Chronic Myeloid Leukemia Treatments (49 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (1.0k citations) and Immunology (869 citations). David A. Sallman has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Alan F. List, Rami S. Komrokji, Eric Padron, Jeffrey E. Lancet, Kendra Sweet, Thomas Cluzeau, Kathy L. McGraw, Anthony M. Hunter, Chetasi Talati and Ashley A. Basiorka. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.